Notice2025-04419
National Center for Advancing Translational Sciences; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 18, 2025
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 51 (Tuesday, March 18, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 51 (Tuesday, March 18, 2025)]
[Notices]
[Page 12545]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-04419]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; NCATS Small Business Innovation and
Small Business Technology Transfer Grants Review Meeting.
Date: April 8-9, 2025.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Meeting Format: Video Assisted Meeting.
Address: National Center for Advancing Translational Sciences,
National Institutes of Health, 9609 Medical Center Drive, Rockville,
MD 20892.
Contact Person: Imoh Sunday Okon, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Center for Advancing
Translational Sciences, National Institutes of Health, 9609 Medical
Center Drive, Suite 1E504, Bethesda, MD 20892. (301) 347-8881,
email: <a href="/cdn-cgi/l/email-protection#f79e9a989fd9989c9899b7999e9fd9909881"><span class="__cf_email__" data-cfemail="8fe6e2e0e7a1e0e4e0e1cfe1e6e7a1e8e0f9">[email protected]</span></a>.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; ZTR1 CI 8(01) Review of Limited
Competition CTSA R03 Applications.
Date: April 10-11, 2025.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Meeting Format: Video Assisted Meeting.
Address: National Center for Advancing Translational Sciences,
National Institutes of Health, 9609 Medical Center Drive, Rockville,
MD 20892.
Contact Person: Ming Yan, MD, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities,
National Center for Advancing Translational Sciences, National
Institutes of Health, 9609 Medical Center Drive, Suite 1E504,
Bethesda, MD 20892, (301) 451-2853, <a href="/cdn-cgi/l/email-protection#187571767f3661797658767170367f776e"><span class="__cf_email__" data-cfemail="84e9edeae3aafde5eac4eaedecaae3ebf2">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: March 13, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-04419 Filed 3-17-25; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 18, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.